| Literature DB >> 11748755 |
P J Reading1, A K Luce, I G McKeith.
Abstract
This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. Copyright 2001 Movement Disorder Society.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11748755 DOI： 10.1002/mds.1204
Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338